ACTRN12610000991011已完成3 期
A randomised placebo-controlled double-masked study to investigate the effects of dietary supplementation with a combination of omega oils on ocular comfort including symptoms of dry eye
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Willing to comply with the dosage and study visit schedule
- •Contact lens wearers and non contact lens wearers
- •At least 18 years old
排除标准
- •Current consumption of omega oil dietary supplements
- •Moderate or severe dry eye disease
- •Systematic disease that would preclude participants from safely ingesting dietary supplementation with omega oils
- •No S3 or above ocular medications
- •No use of any anticoagulants or blood thinning medications
研究者
相似试验
进行中（未招募）
不适用
Efficacy and safety of gevokizumab in the treatment of patients with active non-infectious uveitis currently controlled with systemic treatmentEUCTR2012-001609-25-ITXOMA300
已完成
2 期
A study of DE-127 ophthalmic solution in subjects with myopia - A Phase II/IIIMyopiaJPRN-jRCT2080224816Santen Pharmaceutical co.,Ltd288
进行中（未招募）
1 期
Efficacy of gevokizumab in the treatment of patients with Behçet's disease uveitisEUCTR2012-001125-27-GBInstitut de Recherches Internationales Servier84
进行中（未招募）
不适用
Efficacy of gevokizumab in the treatment of patients with Behçet's disease uveitisEUCTR2012-001125-27-GRInstitut de Recherches Internationales Servier110
进行中（未招募）
不适用
Efficacy of gevokizumab in the treatment of patients with Behçet's disease uveitisBehçet?s disease uveitisMedDRA version: 14.1Level: LLTClassification code 10071139Term: Behcet's uveitisSystem Organ Class: 100000004870EUCTR2012-001125-27-ESaboratorios Servier S.L.110